Cargando…

Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration

Silk fibroin (Bombyx mori) was used to manufacture a nerve conduit (SilkBridge(TM)) characterized by a novel 3D architecture. The wall of the conduit consists of two electrospun layers (inner and outer) and one textile layer (middle), perfectly integrated at the structural and functional level. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Fregnan, Federica, Muratori, Luisa, Bassani, Giulia A., Crosio, Alessandro, Biagiotti, Marco, Vincoli, Valentina, Carta, Giacomo, Pierimarchi, Pasquale, Geuna, Stefano, Alessandrino, Antonio, Freddi, Giuliano, Ronchi, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426473/
https://www.ncbi.nlm.nih.gov/pubmed/32850714
http://dx.doi.org/10.3389/fbioe.2020.00835
_version_ 1783570691832938496
author Fregnan, Federica
Muratori, Luisa
Bassani, Giulia A.
Crosio, Alessandro
Biagiotti, Marco
Vincoli, Valentina
Carta, Giacomo
Pierimarchi, Pasquale
Geuna, Stefano
Alessandrino, Antonio
Freddi, Giuliano
Ronchi, Giulia
author_facet Fregnan, Federica
Muratori, Luisa
Bassani, Giulia A.
Crosio, Alessandro
Biagiotti, Marco
Vincoli, Valentina
Carta, Giacomo
Pierimarchi, Pasquale
Geuna, Stefano
Alessandrino, Antonio
Freddi, Giuliano
Ronchi, Giulia
author_sort Fregnan, Federica
collection PubMed
description Silk fibroin (Bombyx mori) was used to manufacture a nerve conduit (SilkBridge(TM)) characterized by a novel 3D architecture. The wall of the conduit consists of two electrospun layers (inner and outer) and one textile layer (middle), perfectly integrated at the structural and functional level. The manufacturing technology conferred high compression strength on the device, thus meeting clinical requirements for physiological and pathological compressive stresses. As demonstrated in a previous work, the silk material has proven to be able to provide a valid substrate for cells to grow on, differentiate and start the fundamental cellular regenerative activities in vitro and, in vivo, at the short time point of 2 weeks, to allow the starting of regenerative processes in terms of good integration with the surrounding tissues and colonization of the wall layers and of the lumen with several cell types. In the present study, a 10 mm long gap in the median nerve was repaired with 12 mm SilkBridge(TM) conduit and evaluated at middle (4 weeks) and at longer time points (12 and 24 weeks). The SilkBridge(TM) conduit led to a very good functional and morphological recovery of the median nerve, similar to that observed with the reference autograft nerve reconstruction procedure. Taken together, all these results demonstrated that SilkBridge(TM) has an optimized balance of biomechanical and biological properties, which allowed proceeding with a first-in-human clinical study aimed at evaluating safety and effectiveness of using the device for the reconstruction of digital nerve defects in humans.
format Online
Article
Text
id pubmed-7426473
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74264732020-08-25 Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration Fregnan, Federica Muratori, Luisa Bassani, Giulia A. Crosio, Alessandro Biagiotti, Marco Vincoli, Valentina Carta, Giacomo Pierimarchi, Pasquale Geuna, Stefano Alessandrino, Antonio Freddi, Giuliano Ronchi, Giulia Front Bioeng Biotechnol Bioengineering and Biotechnology Silk fibroin (Bombyx mori) was used to manufacture a nerve conduit (SilkBridge(TM)) characterized by a novel 3D architecture. The wall of the conduit consists of two electrospun layers (inner and outer) and one textile layer (middle), perfectly integrated at the structural and functional level. The manufacturing technology conferred high compression strength on the device, thus meeting clinical requirements for physiological and pathological compressive stresses. As demonstrated in a previous work, the silk material has proven to be able to provide a valid substrate for cells to grow on, differentiate and start the fundamental cellular regenerative activities in vitro and, in vivo, at the short time point of 2 weeks, to allow the starting of regenerative processes in terms of good integration with the surrounding tissues and colonization of the wall layers and of the lumen with several cell types. In the present study, a 10 mm long gap in the median nerve was repaired with 12 mm SilkBridge(TM) conduit and evaluated at middle (4 weeks) and at longer time points (12 and 24 weeks). The SilkBridge(TM) conduit led to a very good functional and morphological recovery of the median nerve, similar to that observed with the reference autograft nerve reconstruction procedure. Taken together, all these results demonstrated that SilkBridge(TM) has an optimized balance of biomechanical and biological properties, which allowed proceeding with a first-in-human clinical study aimed at evaluating safety and effectiveness of using the device for the reconstruction of digital nerve defects in humans. Frontiers Media S.A. 2020-08-07 /pmc/articles/PMC7426473/ /pubmed/32850714 http://dx.doi.org/10.3389/fbioe.2020.00835 Text en Copyright © 2020 Fregnan, Muratori, Bassani, Crosio, Biagiotti, Vincoli, Carta, Pierimarchi, Geuna, Alessandrino, Freddi and Ronchi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Fregnan, Federica
Muratori, Luisa
Bassani, Giulia A.
Crosio, Alessandro
Biagiotti, Marco
Vincoli, Valentina
Carta, Giacomo
Pierimarchi, Pasquale
Geuna, Stefano
Alessandrino, Antonio
Freddi, Giuliano
Ronchi, Giulia
Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title_full Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title_fullStr Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title_full_unstemmed Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title_short Preclinical Validation of SilkBridge(TM) for Peripheral Nerve Regeneration
title_sort preclinical validation of silkbridge(tm) for peripheral nerve regeneration
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426473/
https://www.ncbi.nlm.nih.gov/pubmed/32850714
http://dx.doi.org/10.3389/fbioe.2020.00835
work_keys_str_mv AT fregnanfederica preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT muratoriluisa preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT bassanigiuliaa preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT crosioalessandro preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT biagiottimarco preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT vincolivalentina preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT cartagiacomo preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT pierimarchipasquale preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT geunastefano preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT alessandrinoantonio preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT freddigiuliano preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration
AT ronchigiulia preclinicalvalidationofsilkbridgetmforperipheralnerveregeneration